Literature DB >> 23460656

A randomized clinical trial of the efficacy of extended smoking cessation treatment for adolescent smokers.

Steffani R Bailey1, Sarah A Hagen, Christina J Jeffery, Christopher T Harrison, Seth Ammerman, Susan W Bryson, Diana T Killen, Thomas N Robinson, Joel D Killen.   

Abstract

INTRODUCTION: Relatively few well-designed smoking cessation studies have been conducted with teen smokers. This study examined the efficacy of extended cognitive-behavioral treatment in promoting longer term smoking cessation among adolescents.
METHODS: Open-label smoking cessation treatment consisted of 10 weeks of school-based, cognitive-behavioral group counseling along with 9 weeks of nicotine replacement (nicotine patch). A total of 141 adolescent smokers in continuation high schools in the San Francisco Bay Area were randomized to either 9 additional group sessions over a 14-week period (extended group) or 4 monthly smoking status calls (nonextended group). Intention-to-treat logistic regression analysis was used to assess the primary outcome of biologically confirmed (carbon monoxide < 9 ppm) point prevalence abstinence at Week 26 (6-month follow-up from baseline).
RESULTS: At Week 26 follow-up, the extended treatment group had a significantly higher abstinence rate (21%) than the nonextended treatment (7%; OR = 4.24, 95% CI: 1.20-15.02). Females also were more likely to be abstinent at the follow-up than males (OR = 4.15, 95% CI: 1.17-14.71).
CONCLUSIONS: The significantly higher abstinence rate at follow-up for the extended treatment group provides strong support for continued development of longer term interventions for adolescent smoking cessation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23460656      PMCID: PMC3768329          DOI: 10.1093/ntr/ntt017

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  19 in total

Review 1.  Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation.

Authors:  A T McLellan; D C Lewis; C P O'Brien; H D Kleber
Journal:  JAMA       Date:  2000-10-04       Impact factor: 56.272

Review 2.  Smoking cessation interventions for adolescents: a systematic review.

Authors:  Michelle M Garrison; Dimitri A Christakis; Beth E Ebel; Sarah E Wiehe; Frederick P Rivara
Journal:  Am J Prev Med       Date:  2003-11       Impact factor: 5.043

3.  Randomized clinical trial of the efficacy of bupropion combined with nicotine patch in the treatment of adolescent smokers.

Authors:  Joel D Killen; Thomas N Robinson; Seth Ammerman; Chris Hayward; Jayna Rogers; Christi Stone; Deanne Samuels; Sara K Levin; Sarah Green; Alan F Schatzberg
Journal:  J Consult Clin Psychol       Date:  2004-08

4.  Extended nortriptyline and psychological treatment for cigarette smoking.

Authors:  Sharon M Hall; Gary L Humfleet; Victor I Reus; Ricardo F Muñoz; Jennifer Cullen
Journal:  Am J Psychiatry       Date:  2004-11       Impact factor: 18.112

5.  Predicting successful 24-hr quit attempt in a smoking cessation intervention.

Authors:  Steffani R Bailey; Susan W Bryson; Joel D Killen
Journal:  Nicotine Tob Res       Date:  2011-08-10       Impact factor: 4.244

6.  Craving is associated with smoking relapse: findings from three prospective studies.

Authors:  J D Killen; S P Fortmann
Journal:  Exp Clin Psychopharmacol       Date:  1997-05       Impact factor: 3.157

7.  Self-efficacy and smoking reexamined: construct validity and clinical utility.

Authors:  J S Baer; C S Holt; E Lichtenstein
Journal:  J Consult Clin Psychol       Date:  1986-12

8.  Self-efficacy: toward a unifying theory of behavioral change.

Authors:  A Bandura
Journal:  Psychol Rev       Date:  1977-03       Impact factor: 8.934

9.  Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment.

Authors:  K O Fagerström
Journal:  Addict Behav       Date:  1978       Impact factor: 3.913

10.  Nicotine dependence among adolescent smokers.

Authors:  N L Rojas; J D Killen; K F Haydel; T N Robinson
Journal:  Arch Pediatr Adolesc Med       Date:  1998-02
View more
  7 in total

1.  Pharmacological Treatment of Youth Substance Use Disorders.

Authors:  Lindsay M Squeglia; Matthew C Fadus; Erin A McClure; Rachel L Tomko; Kevin M Gray
Journal:  J Child Adolesc Psychopharmacol       Date:  2019-04-22       Impact factor: 2.576

2.  Update of Adolescent Smoking Cessation Interventions: 2009-2014.

Authors:  Patricia Simon; Grace Kong; Dana A Cavallo; Suchitra Krishnan-Sarin
Journal:  Curr Addict Rep       Date:  2015-03

3.  Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation.

Authors:  Jamie Hartmann-Boyce; Bosun Hong; Jonathan Livingstone-Banks; Hannah Wheat; Thomas R Fanshawe
Journal:  Cochrane Database Syst Rev       Date:  2019-06-05

Review 4.  Tobacco cessation interventions for young people.

Authors:  Thomas R Fanshawe; William Halliwell; Nicola Lindson; Paul Aveyard; Jonathan Livingstone-Banks; Jamie Hartmann-Boyce
Journal:  Cochrane Database Syst Rev       Date:  2017-11-17

5.  Influence of family and friend smoking on intentions to smoke and smoking-related attitudes and refusal self-efficacy among 9-10 year old children from deprived neighbourhoods: a cross-sectional study.

Authors:  Ciara E McGee; Joanne Trigwell; Stuart J Fairclough; Rebecca C Murphy; Lorna Porcellato; Michael Ussher; Lawrence Foweather
Journal:  BMC Public Health       Date:  2015-03-07       Impact factor: 3.295

6.  What are the main sources of smoking cessation support used by adolescent smokers in England? A cross-sectional study.

Authors:  Wasif Shaikh; Manjula D Nugawela; Lisa Szatkowski
Journal:  BMC Public Health       Date:  2015-06-19       Impact factor: 3.295

7.  Effect of a sport-for-health intervention (SmokeFree Sports) on smoking-related intentions and cognitions among 9-10 year old primary school children: a controlled trial.

Authors:  Ciara E McGee; Joanne Trigwell; Stuart J Fairclough; Rebecca C Murphy; Lorna Porcellato; Michael Ussher; Lawrence Foweather
Journal:  BMC Public Health       Date:  2016-05-26       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.